The Biomedical Scientist Suppliers Guide 2025 by Redactive Media Group

SUPPLIERS GUIDE 2025

SUPPLIERS GUIDE CONTENTS

WELCOME TO THE OFFICIAL IBMS SUPPLIERS GUIDE

IBMS Chief Executive David Wells on bridging the gap between diagnostic needs and supplier expertise.

At the IBMS we recognise the critical role suppliers play in empowering our members to provide the highest standards of patient care. This guide connects you with the trusted partners, innovative products and expert services your laboratories need to excel.

The healthcare landscape evolves rapidly, with laboratories facing increasing demands to enhance eﬃciency, maintain quality and adopt new technologies. Access to the right tools, expertise and support is essential to meet these challenges. The Biomedical Scientist Suppliers Guide makes those connections easier, providing a comprehensive directory of suppliers committed to supporting your work.

The IBMS’ commitment to fostering collaboration goes beyond providing a list of suppliers. We create an environment where productive partnerships flourish – where members find solutions to enhance services, streamline processes and improve patient outcomes. Suppliers gain opportunities to showcase innovations and demonstrate how their offerings support the critical work in laboratories across the UK.

Our collaborative white papers with industry partners, such as Hologic, BD, Abbott and AstraZeneca, are reinforcing the importance of these relationships. These

publications address crucial topics from earlier diagnostics and digital cytology to community diagnostics and cancer testing, driving progress across the sector. These eﬀorts highlight the necessity of collaboration between suppliers and laboratory professionals to build a resilient, futureready healthcare system.

As we look ahead to IBMS Congress, this guide takes on additional signiﬁcance. The Congress exhibition hall oﬀers premier opportunities for direct engagement between members and suppliers, showcasing the latest diagnostic innovations. Connections established through this guide can lead to meaningful collaborations at Congress and beyond.

The Biomedical Scientist Suppliers Guide is your essential connection to those dedicated to advancing diagnostics. I encourage you to explore proﬁles, reach out to potential partners and seize new opportunities. Every connection contributes to a stronger, more eﬃcient diagnostics sector that delivers better care for patients. Together, we can push the boundaries of what’s possible and ensure the best outcomes for laboratories and patients alike. BS

IN NUMBERS

Biomedical science

From workforce age and diversity, to NHS vacancies, cancer case increases and IBMS diplomas and certiﬁcates issued, we draw on a range of publications and reports to give a snapshot of the biomedical science and wider NHS workforce.

The Health and Care Professions Council diversity

Age of the biomedical scientist workforce

Biomedical scientists’ sex (assigned at birth)

NHS Long Term Workforce Plan

112,000 vacancies

Local NHS services report vacancies totalling over 112,000. This is a reflection of how the needs of our population have grown and changed.

13 years

IBMS Long Term

The number of vacancies is thanks, in large part, to the role better care and advances in medicine have played in increasing life-expectancy by 13 years since 1948.

55% growth

The number of people aged over 85 is estimated to grow 55% by 2037.

360,000 shortfall

Inaction in the face of demographic change is forecast to leave us with a shortfall of up to 360,000 staff by 2036/37.

Cancer Research UK’s Testing times to come?

40% increase

It estimated that, with a growing and ageing population, the projected increase in the number of cancer cases would be more than 40% above current levels.

514,000 cases

The projected increase would lead to a total of about 514,000 new cases per year in 2035.

INTRODUCING THE COMPANY MEMBERS

Who are the Company Members and what is the aim of the scheme? We give an outline of their role and responsibilities.

During 1992, the Institute of Biomedical Science launched the Company Membership scheme and the Company Members Liaison Group, which comprised Company Members and Institute Oﬃcers.

The latter held its ﬁrst meeting in April 1992, which provided an excellent forum to both discuss issues at the Liverpool Triennial and work with exhibitors to transform the event.

Fast-forward to the present and the scheme connects a members’ network of over 20,000 biomedical staﬀ worldwide to many of the leading organisations in biomedical science, covering disciplines across the sector.

Current members of the IBMS Company Members Committee

Mark Reed (Chair) Pro-Lab Diagnostics

Lesley Ayres (Secretary)TCS Biosciences

Leanne Annereau Stago UK

Michelle Coleman Synnovis

David Carter Vector Labs

Helen Tucker Thermo Fisher

James Webber BD

Delivering success

One of the central aims for the scheme is to ensure that members are up to date with the latest developments in technology and advances in scientiﬁc techniques.

Working with the Company Members also enables the delivery of the highly successful annual Congress, while the companies also support local IBMS regional and branch scientiﬁc events and recognise members’ achievements through the award of the Company Members Prize, which is presented to the IBMS member who achieves the highest mark in each specialist subject of the Higher Specialist Diploma examination.

Essential for the future

The IBMS Company Members Committee (see box) works closely with IBMS committees and staﬀ to help organise Congress and strengthen links between biomedical science companies and IBMS members.

Mark Reed, IBMS Company Members Committee Chairman, says: “Open-forum communication between all aspects of the industry, trade association, professional body and working parties is essential for the future of all in this continually changing and challenging business. The partnership between the IBMS and its Company Members continues to be extremely important.” BS

WHAT IS THE 10 YEAR HEALTH PLAN?

What does the next decade of healthcare in the NHS look like? We review the new plans for England and ask what is happening in the devolved countries.

The 10 Year Health Plan for England was launched in July 2025 and focuses on the opportunities provided by new technologies, medicines and innovations to deliver better care for all patients and better value for taxpayers.

The plan is centred around three main transitions in the NHS:

From hospital to community: more care will be available on people’s doorsteps and in their homes.

From analogue to digital: new technology is hoped to liberate staﬀ from admin and

allow people to manage their care as easily as they bank or shop online.

From sickness to prevention: the health service hopes to reach patients earlier and make the healthy choice the easy choice.

The IBMS response

Writing in The Biomedical Scientist magazine, IBMS Chief Executive David Wells welcomed the plan.

“The plan proposes a shift from hospitalbased care to neighbourhood services and more integrated, preventative models. This is welcome. If we can deliver care earlier and closer to where people live, we can reduce

the burden on acute services and improve outcomes. But that system only functions if it is underpinned by timely, accurate and accessible diagnostics - delivered by a skilled and regulated workforce.

“The government’s focus on digital transformation reinforces that point. Biomedical scientists are already driving innovation in AI, data integration and genomics. These technologies can support earlier intervention and better decisionmaking – but only if they’re implemented safely and eﬀectively. The plan promises fully AI-enabled hospitals, expanded access to genomics and digital tools as standard. Our profession will be central to ensuring these tools are clinically useful, quality assured and equitable in practice.”

The devolved nations

The 10 Year Plan focuses on England and does not directly apply to Scotland, Wales, or Northern Ireland, as health and social care are devolved matters and each devolved nation has its own administrations and respective plans for their healthcare systems.

However, the devolved nations are all currently looking to change the way their health services are run.

The Scottish government has outlined an Operational Improvement Plan, a population health framework, and a health and social care service renewal framework and aims to address long waits, reduce health inequalities and improve population health outcomes using digital technology and a cross-sector approach.

NHS Wales is undergoing a transformation that is focused on building a future-ﬁt health service. e key priorities include reducing waiting times, training

more staﬀ, investing in new equipment and moving care closer to home.

A three-year strategic plan for health and social care has been published by the government in Northern Ireland. The plan involves a wide range of initiatives based on three central themes – stabilisation, reform and delivery.

Science and technology

Science and technology are a key element of the 10 Year Health Plan for England. The executive summary says the NHS of the future will be a service that oﬀers instant access to help and appointments; one that predicts and prevents ill health, rather than simply diagnosing and treating it; a patient-controlled system, in place of today’s centralised bureaucracy - and one where frontline staﬀ are empowered to reshape services. It continues to say that the service will have the core principles and values of the NHS but with the know-how of a wider network of technology, life sciences, local government, civil society and third-sector organisations, working in partnership to improve the nation’s health.

AI and genomics

Despite the scale of the challenge faced, the plan says there are more reasons for

optimism than pessimism. It says the NHS is the best placed system in the world to harness the advances we are seeing in AI and genomic science.

The plan describes how the government will use these advantages to propel the NHS into a position of global leadership. When coupled with our country’s excellence in science, innovation and academia, the UK can lead the world in developing the treatments and technologies of the future, it is claimed – this plan will put the NHS at the front of the global genomics revolution and make the NHS the most AI-enabled care system in the world.

Neighbourhood health service

Also in the plans is the “neighbourhood health service”, the idea of which is to bring care into local communities and convene professionals into patient-centred teams. The government says the Neighbourhood Health Service will embody a new preventative principle that care should happen: as locally as it can digitally by default in a patient’s home if possible in a neighbourhood health centre (NHC) when needed in a hospital if necessary. There are a number of ways that the

“A core ambition of our 10 Year Plan will be to provide ﬁrst-class healthcare for everyone”

government plans to drive this change, including: proportionally greater investment in out-of-hospital care; training thousands more GPs and building online advice into the NHS App; establishing an NHC in every community, beginning with places where healthy life expectancy is lowest; expand same-day emergency care services and co-located urgent treatment centres; free up hospitals to prioritise safe deployment of AI and harness new technology to bring the very best of cutting-edge care to all patients.

What the government says

Launching the plan, Health and Social Care Secretary, Wes Streeting, said: “The truth is, those in greatest need often receive the worst quality healthcare. It ﬂies in the face of the values the NHS was founded on. The circumstances of your birth shouldn’t determine your worth. A core ambition of our 10 Year Plan will be to restore the promise of the NHS, to provide ﬁrst=class healthcare for everyone in our country and end the postcode lottery.

“Last year we sent crack teams of top clinicians to hospitals in parts of the country with the highest waiting lists and levels of economic inactivity. It has seen waiting lists in those areas falling twice as fast as the rest of the country, helping get sick Brits back to health and back to work.

“Thanks to the reforms we’ve made to bear down on wasteful spending, we can now invest the savings in working-class communities that need it most. Where towns have the greatest health needs and the fewest GPs, we will prioritise investment to rebuild your NHS and rebuild the health of your community.” BS

HOW THE MAKE-UP OF THE FLU VACCINE IS DECIDED

Earlier this year, the Francis Crick Institute hosted scientists from across the world for a series of data presentations and deliberations, culminating in a decision on which inﬂuenza virus strains will be in the vaccines for the Northern Hemisphere this autumn. Here the team give an insight into the process.

This year, the week of meetings to decide on the make-up of the annual influenza vaccine was held in the UK for the first time since the meeting was first held 70 years ago. Each lab, known as a WHO Collaborating Centre, works throughout the year to gather information on which virus strains are circulating and whether they will respond to current vaccinations and treatments. This is critical as the flu virus is constantly changing, resulting in a need for annual top-up vaccines.

The experts gather twice a year to present their ﬁndings, propose suggestions for which strains are most prevalent and listen to research from other areas of the globe.

This results in decisions on speciﬁc vaccines for the Northern and Southern Hemispheres.

The group also discusses zoonotic viruses, such as bird ﬂu, to assess current risk. They identify which vaccine viruses we need ready and waiting, to be able to produce vaccines if these viruses evolve to spread more easily to and between humans.

Proposed vaccines

Following the week earlier this year there was an announcement including a summary of which strains were circulating, where they were distributed across the world and whether current antiviral drugs or the previous season’s vaccines work against them.

The WHO then announced which three strains they proposed for the two types of

vaccines available for manufacturers to make. They continue to recommend trivalent vaccines, which have three slots –two for A-type ﬂu viruses and one for a B-type ﬂu virus.

The vaccine composition in both types was the same as last year, apart from an update to one of the A viruses in both vaccines. This was to reﬂect that this strain has evolved and the old strain in the vaccine does not match circulating viruses as well. It is predicted that the newer virus may be prevalent in the Northern Hemisphere this autumn.

The group also reported on zoonotic transmission of inﬂuenza from cows and birds and showed whether these strains could be targeted by candidate vaccine viruses already waiting in the wings for production, or if new candidates needed to be made. This allows preparedness for potential future outbreaks.

Best possible recommendations

Following the decision, industrial development of the vaccines kicked into action with manufacturers beginning production as early as possible to ensure that

“There are 3–5 million cases of severe seasonal influenza each year – our best armour is regular vaccination”

the vaccine is ready by October 2025.

Nicola Lewis, Director of the Worldwide Influenza Centre at the Crick, said: “The virus causing flu is constantly evolving and adapting, which means we’re racing to keep up with its movements. It wouldn’t be possible to characterise which strains pose the biggest threat just from our position in the UK; we need information from across the globe to get a full picture. The week-long decision process is hard work but allows us to come to a decision collaboratively and independently of national priorities. We wouldn’t be able to do this without the international nature of science, and flu research specifically.”

Wenqing Zhang, Head of the WHO Global Influenza Programme, said: “There are at least 3–5 million cases of severe seasonal influenza each year and our best armour at the moment is regular vaccination. By bringing together global experts from the Global Influenza Surveillance and Response System (GISRS) and those associated with GISRS at this meeting, we make the best possible recommendations on viruses to be included in vaccines for use in the upcoming Northern Hemisphere season.

“We also stay on top of avian and swine influenza virus evolution and associated risks to humans, develop new candidate vaccine viruses to support countries’ prevention and control strategies, respond to avian and swine influenza outbreaks, and prepare for an influenza pandemic that might occur at any moment.” BS

Four

recommendations

The IBMS and global consultancy PA Consulting have released the report Earlier Diagnostics: End-to-End Diagnostic Pathways, which outlines critical improvements needed across all stages of the diagnostic process. It concludes with four recommendations.

Standardising the pre-analytical phase: Establishing uniform protocols for sample collection, labelling, and transportation, complemented by real-time tracking systems. This reduces errors and ensures quicker, more reliable sample handling.

Enhancing analytical efficiency with automation and AI: Implementing laboratory automation and AI-driven diagnostics to streamline test processing, prioritise urgent cases, and maintain high accuracy, easing strain on laboratory staff.

Improving post-analytical communication: Integrating diagnostic IT systems with clinical care platforms to provide faster, transparent result reporting to clinicians and patients, ensuring clear, actionable data that supports informed healthcare decisions.

4 Bringing diagnostics closer to patients: Expanding communitybased diagnostic centres and home testing solutions, thereby ensuring equitable access, particularly for underserved communities. Initiatives such as community diagnostic centres demonstrate the potential to reduce delays and improve overall patient care.

David Wells, IBMS Chief Executive, said: “Improving diagnostics is not only about speed – it’s about shifting towards prevention and ensuring equitable care. By optimising every stage of the diagnostic pathway, we can signiﬁcantly improve patient outcomes and build a sustainable, responsive healthcare system.”

LISTINGS 2025 SUPPLIER

1 AI, DIGITAL TECH AND IT

KEY

CC Clinical chemistry

C Cytopathology

HT Haemotology & transfusion science

H Histopathology

I Immunology

MV Microbiology & virology

MG Molecular pathology & genomics

ABBOTT DIAGNOSTICS UK

T: 01628 773355

E: lisa.harrison@abbott.com

W: www.corelaboratory.abbott/int/en/home

Key contact: Judy Barber

BIOMERIEUX UK LTD

T: 01256 461881

E: ukmarketing@biomerieux.com

W: www.biomerieux.com

Key contact: Lauren Campbell

As a world leader in microbiology for 60 years, bioMérieux is committed to major public health issues in the ﬁeld of infectious diseases, such as antimicrobial resistance, respiratory infections and sepsis.

bioMérieux provides innovative end-toend diagnostic solutions that improve patient outcomes, help prevent antimicrobial resistance and improve antimicrobial stewardship, as well as empowering clinicians and laboratorians in decision making by providing actionable data through integrated IT and DATA solutions.

CIRDAN LTD

T: 02892 660880

E: info@cirdan.com

W: www.cirdan.com

Key contact: Rebecca Fitton

Cirdan is a leading provider of pathology informatics and imaging solutions that support and speed up patient diagnosis. Cirdan is recognised as one of the leading suppliers of laboratory information systems (LIS) worldwide. Our products include ULTRA, a LIS that supports and streamlines clinical laboratory operations, specimen x-ray cabinets which expedite breast cancer diagnosis and Tutor, a digital pathology education platform. With additional solutions that support artiﬁcial intelligence and machine learning in digital pathology technologies. Find out more at www.cirdan.com.

CLINISYS

T: 01932 581200

E: info-uk@clinisys.com

W: www.clinisys.co.uk

Key contact: Matthew Fouracre H MG

Clinisys is a global provider of intelligent diagnostic informatics solutions and expertise designed to redeﬁne the modern laboratory, across healthcare, life sciences, and public health. Millions of diagnostic results and data insights are generated every day using Clinisys’ solutions in over 3,000 laboratories across 34 countries. Our WinPath LIMS is installed in over 60% of NHS labs across the UK.

GENMED

T: 03454 502204

E: enquiries@genmed.eu

W: www.genmed.eu

HOLOGIC

T: 01619 462200

E: euinfo@hologic.com

W: www.hologic.com

Key contact: Fiona Smith

INTERSYSTEMS

T: 01753 855450

E: info@intersystems.com

W: www.intersystems.com/uk

INTEGRATED SOFTWARE SOLUTIONS LTD

T: 01962 807 600

E: info@intsoftsol.com

W: www.iss-lims.com

Key contact: Tony Carter

LEICA BIOSYSTEMS

T: 0800 011 9620

E: support.uk@leicabiosystems.com

W: www.leicabiosystems.com

Key contact: Rachel Aldridge/Lily Kremer H I

MEDILIMS

T: +44 (0) 345 366 9764

E: sales@medilims.co.uk

W: www.medilims.co.uk

Key contact: Pardip Nayyar

MediLIMS is an advanced Laboratory Information Management System (LIMS) for diagnostic pathology, veterinary and commercial clinical laboratories. Our browser-based software supports all medical disciplines. Key features include sample tracking, workflow automation, seamless integration to analysers and digital pathology, regulatory compliance assistance, billing and invoicing. MediLIMS is available as a cloud-based or on-premises solution, ensuring scalability for both small laboratories and large multi-site operations, allowing cross site working, security and a comprehensive audit trail. Visit us on www.medilims.co.uk for more information.

NIKON UK LTD

T: 020 8247 1717

E: discover.uk@nikon.com

W: www.nikon.co.uk/en_GB

Key contact: Natalia Alexander H MV

PFMMEDICAL UK

T: 01625 875388

E: uk@pfmmedical.com

W: www.pfmmedical.co.uk/products/ histotechnology/

Key contact: Jemma Heath H

ROCHE DIAGNOSTICS

T: 01444 256000

E: burgesshill.marketing@roche.com

W: www.diagnostics.roche.com

CC MG

At Roche Diagnostics we believe time is precious and we are dedicated to providing diagnostic tests and services that give people more time with their loved ones. We are proud to be the UK’s leading provider of in vitro diagnostics tests1 and in 2020 more than 820 million Roche diagnostic tests were used by clinicians across the UK to conﬁrm, rule out or manage health conditions including cancer, heart disease, diabetes, COVID-19, hepatitis, human papillomavirus (HPV) and many others2

1 Data on ﬁle

2Business Intelligence Team at Roche Diagnostics

SAVANT LIMITED

T:01524 784400

E:Salesandmarketing@savant.co.uk

W: www.savant.co.uk

Key Contact: Andrew Ashford

Since 1980, Savant has been a long-established SME with experience in providing innovative solutions for critical business processes. Services include project management, software design, development, implementation and support (24/7), as well as migration, testing, planning and advisory services for cloud projects.

Savant is accredited with ISO:9001 and ISO:27001 and uses ISBT128 compliant labels.

SOURCE LDPATH

T: 0115 9739012

E: enquiries@sourcebioscience.com

W: www.sourcebioscience.com

Key contact: Klaudyna Johnstone I MG

Source LDPath provides an end-to-end clinical healthcare service from histopathology, including digital pathology and AI, through to molecular diagnostics services; bringing a comprehensive workflow for the delivery of pathology diagnostics and precision therapeutics. With market-leading turnaround times, Source LDPath is committed to driving the delivery of precision healthcare. Offering a unique modular integration model, the company supports the implementation of digital pathology in routine practice, aiding over 80 NHS Trusts and private pathology departments.

2 ANALYSERS & AUTOMATION

KEY

CC Clinical chemistry

C Cytopathology

HT Haemotology & transfusion science

H Histopathology

I Immunology

MV Microbiology & virology

MG Molecular pathology & genomics

ABBOTT DIAGNOSTICS UK

T: 01628 773355

E: lisa.harrison@abbott.com

W: www.corelaboratory.abbott/int/en/home

Key contact: Judy Barber

AB SCIENTIFIC LTD

T: 020 8396 6171

E: info@abscientiﬁc.com

W: www.abscientiﬁc.com

Key contact: Nigel Baron

ADVANCED INSTRUMENTS LTD

T: 01403 210400

E: ukorders@aicompanies.co.uk

W: www.aicompanies.co.uk

Key contact: Jim Smith

AESKU UK LTD

T: +44 330 027 1644

E: ukcustomerservices@aesku.com

W: www.Aesku.com

Key contact: Anthony Celli

AGILENT TECHNOLOGIES

LDA UK LIMITED

T: 08457 125292

E: customercare_uk@agilent.com

W: www.agilent.com

ASPECT SCIENTIFIC

T: 01829 824825

E: info@aspectscientiﬁc.com

W: www.aspectscientiﬁc.com

A. MENARINI DIAGNOSTICS

T: 0118 944 4100

E: enquiries@menarinidiag.co.uk

W: www.menarinidiag.co.uk

Key contact: Mira Pasanen

A.Menarini Diagnostics is committed to bringing innovative solutions to the clinical diagnostics market, providing healthcare professionals with the best possible solutions for their diagnostics needs and to improve patients’ quality of life. We address laboratory needs for infectious diseases, diabetes management, urinanalysis and haematology. We offer solutions for different laboratories such as biochemistry, microbiology, molecular, point of care and histopathology. In addition, we offer innovative tube labelling solutions for pre-analytics.

BD - BECTON DICKINSON

T: 0800 917 8776

E: BDdiagnosticsUKI@bd.com

W: www.bd.com/en-uk

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. bd.com.

BECKMAN COULTER UK LTD

T: 01494 441181

E: infouk@beckman.com

W: www.beckmancoulter.com

Key contact: Sue Crowe

BIOMERIEUX UK LTD

T: 01256 461881

E: ukmarketing@biomerieux.com

W: www.biomerieux.com

Key contact: Lauren Campbell I MV

BIO-RAD LABORATORIES LTD

T: 01923 471301

E: Contact_NorthEurope@bio-rad.com

W: www.bio-rad.com

CEPHEID UK LTD

T: 01628 564000

E: sales@cepheideurope.co.uk

W: www.cepheid.com

Key contact: Edward Levitt

COPAN ITALIA SPA

T: +39 030 2687211

E: customercare@copangroup.com

W: www.copangroup.com

Key contact: Alessia Tomasi

ELITECH UK LTD

T: 01442 869320

E: sales@elitechuk.com

W: www.elitechgroup.com

Key contact: Lee Roberts

ELKAY LABORATORY PRODUCTS (UK) LTD

T: 01256 811118

E: sales@elkaylabs.com

W: www.elkaylabs.com

Key contact: Robin Conway

EUROBIO SCIENTIFIC UK LTD

T: +44 (0)1306888777

E: sales@eurobio-scientiﬁc.co.uk

W: www.eurobio-scientiﬁc.co.uk

Key contact: Rob Cordingley

Eurobio Scientiﬁc is a manufacturer and distributor of reagents, controls, calibrators, and instrumentation in the ﬁelds of Blood Sciences, Molecular Biology, Life Sciences and Transplantation to Clinical Diagnostic and Research Laboratories.

Eurobio Scientiﬁc also operates its online, independent PathQAS Quality Assurance

Schemes to help customers comply with ISO 15189:2022.

Product Listing

Haemostasis & Biochemistry - reagents and instruments

Molecular - Extraction and PCR Kits

Immunology QC - Allergy, Autoimmunity

Calprotectin QC

FungiLine

Bone and Cartilage Markers

Diabetes and Obesity Markers

Transplantation.

FUJIFILM UK LTD

T: +44 (0)7584 441255

E: katherine.john@fujiﬁlm.com

W: www.fujimed.co.uk

Key contact: Katherine John

GILSON

T: 0845 519 6872

E: customersupport-uk@gilson.com

W: www.gilson.com

Key contact: Dave Rooks

GRIFOLS UK LIMITED

T: 01223 395709

E: ukdiagnostic@grifols.com

W: www.grifols.com

Key contact: Pat Lynch

GT VISION LTD

T: 01284 789697

E: sales@gtvision.co.uk

W: www.gtvision.co.uk

Key contact: Neil Patterson

Established 20+ years, GT Vision Ltd. is a specialist UK-owned microscope company with a wealth of experience and knowledge in microscope sales, installation, training, service and repair.

We are main agents for Leica microscopes and other ﬁrmly established brands, and additionally offer our own extensive and more affordable range of microscopes, accessories, cameras and scanning systems.

Our dedicated service and support department offers repairs, plus routine and contract service for almost any make, model and age of microscope.

HOLOGIC

T: 01619 462200

E: euinfo@hologic.com

W: www.hologic.com

Key contact: Fiona Smith

HORIBA UK LIMITED

T: 01604 542550

E: sales.hduk@horiba.com

W: www.horiba.com/uk

Key contact: Tariq Neiman

ILLUMINA CAMBRIDGE LTD

T: +44 (0)7823 662063

E: raldridge@illumina.com

W: https://emea.illumina.com

Key contact: Rachel Aldridge/Lily Kremer

IMMUCOR

T: +44 (0)330 333 8742

E: uk-sales@immucor.com

W: www.immucor.com

Key contact: Patrick Lynch

INTEGRATED SOFTWARE SOLUTIONS LTD

T: 01962 807 600

E: info@intsoftsol.com

W: www.iss-lims.com

Key contact: Tony Carter

LAUNCH DIAGNOSTICS LIMITED

T: 01474 874426

E: enquiries@launchdiagnostics.com

W: www.launchdiagnostics.com

Key contact: Chris Waghorn I MV MG

Launch Diagnostics is a leading supplier of diagnostic solutions for many pathology disciplines. Launch partners with world leading manufacturers, supplying high quality diagnostic reagents, instrumentation, and services to pathology departments across the public & private sector throughout the UK, Ireland (ACCUSAY Diagnostics) and Europe.

Key instruments for Microbiology and Virology include the AIX1000 automated RPR instrument and the VirCLIA lotus serology platform. Our product repertoire includes serology, molecular, 3rd party QC and extensive AMR solutions, providing a single-supplier solution for your microbiology and virology service.

To discuss our instruments and products, visit our website www.launchdiagnostics.com.

LEICA BIOSYSTEMS

T: 0800 011 9620

E: support.uk@leicabiosystems.com

W: www.leicabiosystems.com H I

LGC STANDARDS

T: 020 8943 8480

E: uksales@lgcgroup.com

W: www.lgcstandards.com/GB/en

MAST GROUP LTD.

T: 0151 933 7277

E: sales@mast-group.com

W: www.mast-group.com

Key contact: Rachel Shelmerdine

A manufacturer and global supplier of in vitro diagnostic products. Mast is a pioneer of antibiotic susceptibility testing (AST), and has over 65 years’ experience in this ﬁeld, supporting the AMR challenge by continually updating its portfolio of AST and AMR products. Another core product is the widely established MAST URI®SYSTEM, which streamlines and optimises urine microbiology. Mast offers a range of Molecular diagnostic solutions and supplies OC-Sensor™ - the world leading solution for quantitative Faecal Immunochemical Testing (FIT).

NOVA BIOMEDICAL

T: 01928 704040

E: uk-info@novabio.com

W: www.novabiomedical.com

A world leader in point-of-care and critical care IVD. Stat Proﬁle Prime Plus® critical care blood gas analyser features a 22-test menu including iMg, Creatinine, ePV and Co-oximetry. StatStrip® Glucose/Ketone provides lab-accurate measurements while eliminating interferences. StatStrip® Lactate/Hb/Hct offers screening and monitoring of sepsis or an alternative to fetal scalp pH testing; the Hb/Hct strip provides rapid anaemia assessment. StatSensor® Creatinine measures capillary whole blood creatinine and calculated eGFR for assessment of renal function prior to contrast media in radiology.

OXFORD BIOSYSTEMS LTD

T: 01235 431390

E: sales@oxfordbiosystems.com

W: www.oxfordbiosystems.com

Key contact: Fiona Alcock

PRO-LAB DIAGNOSTICS

T: 01513 531613

E: uksupport@pro-lab.com

W: www.pro-lab.co.uk

PROMEGA UK LTD

T: 02380 760225

E: ukcustserve@promega.com

W: www.promega.co.uk

QIAGEN

T: 0161 2041100

E: customercare-us@qiagen.com

W: www.qiagen.com

QUADRATECH DIAGNOSTICS LTD

T: 033 3321 2371

E: info@quadratech.co.uk

W: www.quadratech.co.uk

Key contact: Graham Jones

QUIDEL ORTHO

T: +44 1628 485122

E: QONorthernEurope@quidelortho.com

W: www.quidelortho.com

RADIOMETER LIMITED

T: 01293 517599

E: sales@radiometer.co.uk

W: www.radiometer.co.uk

Key contact: Andrew Masters

CC C

As a world leader in providing technologically advanced acute care solutions at the point-ofcare, Radiometer’s mission is to help caregivers make diagnostic decisions that save lives, improve patient care and optimise patient flow. Our products include Blood gas analysis, measuring creatinine and urea from a single sample needing only 65μl of blood with results ready in 35 seconds. Blood gas syringes, Immunoassay testing, Haemoglobin testing, IT and Data Management and Remote support.

RANDOX LABORATORIES LTD

T: 02894 422413

E: marketing@randox.com

W: www.randox.com

CC MV

For 40 years, Randox has developed an expertise in diagnostics and fielded a portfolio of revolutionary solutions in our commitment to improve health globally, including openchannel reagents in addition to chemistry, immunoassay and POC analysers. Our trusted market-leading quality-control includes daily QC, calibration verification and proficiency testing. Randox’s unique multiplex Biochip technology has disrupted the in-vitro diagnostic market, offering clinical, research and molecular panels. Randox products are designed to improve and streamline processes of laboratories of all sizes and requirements.

ROCHE DIAGNOSTICS

T: 01444 256000

E: burgesshill.marketing@roche.com

W: www.diagnostics.roche.com

CC MG

1 Data on ﬁle 2Business Intelligence Team at Roche Diagnostics

SAKURA FINETEK UK LTD

T: +44 (0)845 070 1638

E: uk@sakura.eu

W: www.sakura.e

Key contact: Wesley Gater H

When it comes to diagnosing cancer, there’s no time to wait. Sakura is driven by our desire to advance cancer diagnosis through fully automated anatomic pathology. From our expertise with the ﬁrst-ever Japanese microscope in 1871, to being the original manufacturer of Tissue-Tek® technology for key pathology processes. Since 2022, by having Tissue-Tek Genie®in our portfolio, we also provide solutions in immunohistochemistry (IHC). Visit us to learn how you best setup your lab for digital pathology.

SURESCREEN DIAGNOSTICS

T: 01332 365318

E: info@surescreen.com

W: www.surescreen.com CC

SureScreen Diagnostics is a UK-based, awardwinning manufacturer and supplier of innovative diagnostic solutions. Partnering with NHS trusts, pathology networks and clinical laboratories, we deliver high quality products that support timely clinical decisions.

Our portfolio includes:

Rapid lateral flow tests for respiratory infections incl. dual Influenza/COVID-19, Mpox, RSV and other infectious diseases

Point-of-Care Testing solutions for immediate clinical decision-making

Comprehensive Drug & Alcohol testing solutions incl. rapid test devices, lab conﬁrmations and chain-of-custody kits

Custom R&D partnerships for tailored diagnostic development

On-site occupational health services to help prevent work-related illness or injury

SureScreen Diagnostics also provides expert consultancy, technical support and training, ensuring seamless integration into clinical and laboratory workflows.

SEBIA

T: 01276 600636

E: info@sebia.co.uk

W: www.sebia.com/en-UK

Key contact: Kayleigh Kirk HT I

SEROSEP UK LIMITED

T: +44 (0)129 388 9215

E: info@serosep.com

W: www.serosep.com

Key contact: Nathan Reading I MV

Serosep specialise in the manufacture and distribution of high-performance diagnostic solutions. Among our innovations is EntericBio, a versatile molecular enteric testing platform capable of swiftly detecting and identifying a spectrum of GI pathogens - Bacteria, Parasites and Viruses - within a single workflow, delivering results in just 3 hours. Moreover, over the past 25 years, Serosep has fostered vital distribution partnerships with esteemed entities such as Axonlab, Bio-Rad, Alifax, Thermoﬁsher Scientiﬁc and Dynex.

SHIMADZU

T: 01908 552209

E: info@shimadzu.co.uk

W: www.shimadzu.co.uk

Key contact: Patty Pan CC

SIEMENS HEALTHCARE DIAGNOSTICS LTD

T: 01787 880022

E: customercare.gb@siemens-healthineers. com

W: www.healthcare.siemens.co.uk

STAGO UK LTD

T: 08450 540614

E: stago-uk@stago.com

W: www.stago-uk.com

UNA HEALTH LTD

T: 01782 575180

E: enquiries@unahealth.co.uk

W: www.unahealth.co.uk

SUSSEX BIOLOGICALS LTD

T: 01323849944

E: peter.nest@sussexbiologicals.co.uk

W: www.sussexbiologicals.co.uk

Key contact: Peter Nest

Sussex Biologicals is a manufacturer of IVD solutions for use in transfusion and transplant laboratories. The company also develops and supports Bank Manager, BT LIMS system, and POC-net connectivity for POCT. The company is exclusive distributor for Inno-Train GmbH, supplying PCR and NGS based tests for RBC and HLA typing. SBL is the exclusive distributor Llusern Scientiﬁc for the Lodestar POCT analyser which offers DNA based identiﬁcation of the 6 most common bacterial pathogens in urine in only 35 minutes.

SYSMEX UK LTD

E: sales@sysmex.co.uk

W: www.sysmex.co.uk

Key contact: Andy Foster

TECHNIDATA UK

T: 01925 811277

E: uk@technidata-web.com

W: www.technidata-web.com/en-gb

THERMO FISHER DIAGNOSTICS

T: 01256 694288

E: tenders.tfdl@thermoﬁsher.com

W: www.thermo.com

Key contact: Helen Johnstone

TOSOH BIOSCIENCE LTD

T: 01527 592901

E: info.diag.uk@tosoh.com

W: www.diagnostics.eu.tosohbioscience.com

Key contact: Stephanie Shaw

VH BIO LIMITED

T: 0191 495 8210

E: info@vhbio.com

W: www.vhbio.com

Key contact: James Briggs

WERFEN LTD

T: 01925 810141

E: sales.uk@werfen.com

W: www.werfen.co.uk

Key contact: Richard Hames

WOODLEY EQUIPMENT COMPANY LTD

T: +44 1204 460446 (Option 1)

E: sales@woodleyequipment.com

W: www.woodleyequipment.com

Key contact: Customer Services

DIAGNOSTIC KIT REAGENTS

KEY

CC Clinical chemistry

C Cytopathology

HT Haemotology & transfusion science

H Histopathology

I Immunology

MV Microbiology & virology

MG Molecular pathology & genomics

A. MENARINI DIAGNOSTICS

T: 0118 944 4100

E: enquiries@menarinidiag.co.uk

W: www.menarinidiag.co.uk

Key contact: Mira Pasanen

AB SCIENTIFIC LIMITED

T: 020 8396 6171

E: info@abscientiﬁc.com

W: www.abscientiﬁc.com

Key contact: Nigel Baron

AESKU UK LTD

T: +44 330 027 1644

E: ukcustomerservices@aesku.com

W: www.Aesku.com

Key contact: Anthony Celli

AGILENT TECHNOLOGIES

LDA UK LIMITED

T: 08457 125292

E: customercare_uk@agilent.com

W: www.agilent.com

ALPHA LABORATORIES LTD

T: 023 8048 3000

E: marketing@alphalabs.co.uk

W: www.alphalabs.co.uk

Key contact: Carole Staniford

ALSACHIM

T: +33 (0) 390 402 200

E: contact@alsachim.com

W: www.alsachim.com

Key contact: Sibylle Collard

ATOM SCIENTIFIC LTD

T: 0161 366 5123

E: enquiries@atomscientiﬁc.com

W: www.atomscientiﬁc.com

Key contact: Yvonne Black

BD - BECTON DICKINSON

T: 0800 917 8776

E: BDdiagnosticsUKI@bd.com

W: www.bd.com/en-uk

BECKMAN COULTER UK LTD

T: 01494 441181

E: infouk@beckman.com

W: www.beckmancoulter.com

Key contact: Sue Crowe

BIO-RAD LABORATORIES LTD

T: 01923 471301

E: Contact_NorthEurope@bio-rad.com

W: www.bio-rad.com

BIOCONNECTIONS

T: 01782 516010

E: welcome@bioconnections.co.uk

W: www.bioconnections.co.uk

Key contact: Andrew Wood MV MG

BioConnections is a leading distributor in the UK, specialising in diagnostic testing solutions for clinical microbiology. We are committed to empowering healthcare professionals with reliable solutions that facilitate accurate diagnosis and effective patient care.

Our portfolio includes a wide range of diagnostic reagents and reliable instruments including:

Carbapenemase Identiﬁcation and Detection Kits

Chromogenic Culture Media

Faecal Parasite Concentrator Kits

IVD Quality Control Reagents

LAMP and Lateral Flow Assays

Susceptibility Testing by BMD

Typing Sera for Salmonella, Shigella, and E. coli.

CELLPATH LTD

T: 01686 611333

E: info@cellpath.com

W: www.cellpath.com

Key contact: Stacey Rogers H

CEPHEID UK LTD

T: 01628 564000

E: sales@cepheideurope.co.uk

W: www.cepheid.com

Key contact: Edward Levitt MV

COPAN ITALIA SPA

T: +39 030 2687211

E: customercare@copangroup.com

W: www.copangroup.com

Key contact: Alessia Tomasi MV MG

DIACEUTICS

T: 02678 008163

E: info@diaceutics.com

W: www.diaceutics.com

DX GROUP

T: 0333 241 5100

E: health@thedx.co.uk

W: www.dxdelivery.com

Key contact: Jonathan Ramsey

ELITECH UK LTD

T: 01442 869320

E: sales@elitechuk.com

W: www.elitechgroup.com

Key contact: Lee Roberts

EUROBIO SCIENTIFIC UK LTD

T: +44 (0)1306888777

E: sales@eurobio-scientiﬁc.co.uk

W: www.eurobio-scientiﬁc.co.uk

Key contact: Rob Cordingley HT MG

Eurobio Scientiﬁc also operates its online, independent PathQAS Quality Assurance Schemes to help customers comply with ISO 15189:2022.

Product Listing

Haemostasis & Biochemistry - reagents and instruments

Molecular - Extraction and PCR Kits

Immunology QC - Allergy, Autoimmunity

Calprotectin QC

FungiLine

Bone and Cartilage Markers

Diabetes and Obesity Markers

Transplantation.

EUROIMMUN UK

T: 02085 407058

E: info@euroimmun.co.uk

W: www.euroimmun.co.uk

Key contact: Lee Craddock

FUJIFILM UK LTD

T: 01234 572209

E: louise.barlow@fujiﬁlm.com

W: www.fujimed.co.uk

Key contact: Louise Barlow

GENETIC SIGNATURES

T: +44 (0)330 828 0813

E: EMEA@geneticsignatures.com

W: www.geneticsignatures.com/EU

Key contact: John Buckels MV

Genetic Signatures specialise in syndromic testing of infectious diseases.

Our proprietary 3base™ technology, reduces the genetic complexity of target pathogens and enables uniform sample processing across specimen types.

Our EasyScreen™ assays automated end-toend workflow reduces operator intervention, PCR speciﬁc and sensitive detection of multiple pathogens in a single sample for up to 46 samples in 4.5hrs.

Genetic Signatures unique syndromic solutions can help your lab to improve diagnostic workflow and efficiencies, reduce costs, and improve patient management and disease surveillance.

GENTA ENVIRONMENTAL LTD

T: 01423 358128

E: info@gentamedical.co.uk

W: www.gentamedical.co.uk

Key contact: Carol Johnson, Claire Redpath

GREINER BIO-ONE LTD

T: 01453 825255

E: info@uk.gbo.com

W: www.gbo.com

Key contact: Nick Rudge

GRIFOLS UK LIMITED

T: 01223 395709

E: ukdiagnostic@grifols.com

W: www.grifols.com

Key contact: Pat Lynch

HORIBA UK LIMITED

T: 01604 542550

E: sales.hduk@horiba.com

W: www.horiba.com/uk

Key contact: Tariq Neiman

IMMUCOR

T: +44 (0)330 333 8742

E: uk-sales@immucor.com

W: www.immucor.com

Key contact: Patrick Lynch

LAUNCH DIAGNOSTICS LIMITED

T: 01474 874426

E: enquiries@launchdiagnostics.com

W: www.launchdiagnostics.com

Key contact: Chris Waghorn I MV MG

To discuss our instruments and products, visit our website www.launchdiagnostics.com.

LEICA BIOSYSTEMS

T: 0800 011 9620

E: support.uk@leicabiosystems.com

W: www.leicabiosystems.com

Key contact: Rachel Aldridge/Lily Kremer H I

MAST GROUP LTD.

T: 0151 933 7277

E: sales@mast-group.com

W: www.mast-group.com

Key contact: Rachel Shelmerdine MV MG

MWE (MEDICAL WIRE & EQUIPMENT CO. ) LTD.

T: 01225 810361

E: info@mwe.co.uk

W: www.mwe.co.uk

Key contact: Lucy Pulman MV MG

Medical Wire & Equipment Co. (Bath) Ltd has been at the forefront of laboratory sciences and developing pre-analytical medical devices for over 70 years. Our innovation is led by ﬁnding solutions to our customers challenges. MWE manufactures a wide range of products such as swabs and specimen collection media for the safe handling, collectionand transportation of viruses, bacteria, and other microorganisms. Contact us to ﬁnd out how we can support you.

NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL (NIBSC)

E: business@nibsc.org

W: www.nibsc.org

Key contact: Faraz Farooqi

OXFORD BIOSYSTEMS LTD

T: 01235 431390

E: sales@oxfordbiosystems.com

W: www.oxfordbiosystems.com

Key contact: Fiona Alcock

PROMEGA UK LTD

T: 023 8076 0225

E: ukcustserve@promega.com

W: www.promega.co.uk

QIAGEN

T: 0161 2041100

E: customercare-us@qiagen.com

W: www.qiagen.com

QUADRATECH DIAGNOSTICS LTD

T: 033 3321 2371

E: info@quadratech.co.uk

W: www.quadratech.co.uk

Key contact: Graham Jones HT

RADIOMETER LIMITED

T: 01293 517599

E: sales@radiometer.co.uk

W: www.radiometer.co.uk

Key contact: Andrew Masters

CC C

R-BIOPHARM

T: +49 (0)6151 81020

E: info@r-biopharm.de

W: www.r-biopharm.com

ROCHE DIAGNOSTICS

T: 01444 256000

E: burgesshill.marketing@roche.com

W: www.diagnostics.roche.com CC MG

1 Data on ﬁle

2Business Intelligence Team at Roche Diagnostics

SCHEBO BIOTECH UK LIMITED

T: 01256 477259

E: info@schebo.co.uk

W: www.schebo.co.uk

Key contact: Ivor Smith

SCILABWARE LTD

T: 01782 444406

E: enquiries@scilabware.com

W: www.scilabware.com

SEBIA

T: 01276 600636

E: info@sebia.co.uk

W: www.sebia.com/en-UK

Key contact: Chris Plows

SEROSEP UK LIMITED

T: +44 (0)129 388 9215

E: info@serosep.com

W: www.serosep.com

Key contact: Nathan Reading

SHIMADZU

T: 01908 552209

E: info@shimadzu.co.uk

W: www.shimadzu.co.uk

Key contact: Patty Pan

SYSMEX UK LTD

T: 0333 320 3460

E: sales@sysmex.co.uk

W: www.sysmex.co.uk

Key contact: Andy Foster

TCS BIOSCIENCE LTD

T: 01296 714222

E: sales@tcsgroup.co.uk

W: www.tcsbiosciences.co.uk

Key contact: Lesley Ayres

TECHNOPATH DISTRIBUTION LTD

T: +353 61 335844

E: info@techno-path.com

W: www.techno-path.com

Key contact: Des Joyce

THE BINDING SITE GROUP LTD

T: 01214 569500

E: info@bindingsite.co.uk

W: www.bindingsite.com/en

THERMO FISHER DIAGNOSTICS

T: 01256 694288

E: tenders.tfdl@thermoﬁsher.com

W: www.thermo.com

Key contact: Helen Johnstone

TOSOH BIOSCIENCE LTD

T: 01527 592901

E: info.diag.uk@tosoh.com

W: www.diagnostics.eu.tosohbioscience.com

Key contact: Stephanie Shaw

UNA HEALTH LTD

T: 01782 575180

E: enquiries@unahealth.co.uk

W: www.unahealth.co.uk

MICROSCOPY & IMAGING

CC Clinical chemistry

C Cytopathology

HT Haemotology & transfusion science

H Histopathology

I Immunology

MV Microbiology & virology

MG Molecular pathology & genomics

A. MENARINI DIAGNOSTICS

T: 0118 944 4100

E: enquiries@menarinidiag.co.uk

W: www.menarinidiag.co.uk

Key contact: Mira Pasanen CC HT H MV MG

A. Menarini Diagnostics is active in the ﬁelds of HbA1c, histopathology, autoimmunity, infectious diseases, haemoglobinopathy and molecular pathology. With a historically strong presence in the HbA1c and urine sediment markets, the company has more recently expanded to offer a Total Tissue DiagnosticsTM solution in histology, the innovative Zenit Pro for autoimmunity, and a range of both point of care and laboratory infectious disease systems. Menarini is committed to innovation, with a constant stream of leadingedge products in the development pipeline.

BRIGHT INSTRUMENTS CO LIMITED

T. 0808 168 9697

E. sales@brightinstruments.com

W. https://www.brightinstruments.co.uk/

Key contact: Gareth Humphries

Quality results in microscopy & imaging demand quality tissue specimen preparation.

Established in 1937; Bright Instruments is a privately owned UK-based business, with a strong reputation for the supply of quality Cryostats and Microtomes. The OTF7000 Cryostat and 7010 Microtome are our most precise instruments yet; offering intuitive operation, efficient specimen process, sustainable performance & most importantly reproducible, high quality sections. We offer UK stock, UK engineers, and excellent customer support. Bright Instruments; Brighter Insights

CIRDAN LTD

T: 02892 660880

E: info@cirdan.com

W: www.cirdan.com

Key contact: Rebecca Fitton

EUROIMMUN UK

T: 02085 407058

E: info@euroimmun.co.uk

W: www.euroimmun.co.uk

Key contact: Lee Craddock

GREINER BIO-ONE LTD

T: 01453 825255

E: info@uk.gbo.com

W: www.gbo.com

Key contact: Nick Rudge

GT VISION LTD

T: 01284 789697

E: sales@gtvision.co.uk

W: www.gtvision.co.uk

Key contact: Neil Patterson

Established 20+ years, GT Vision Ltd. is a specialist UK-owned microscope company with a wealth of experience and knowledge in microscope sales, installation, training, service and repair.

Our dedicated service and support department offers repairs, plus routine and contract service for almost any make, model and age of microscope.

ILLUMINA CAMBRIDGE LTD

T: +44 (0)7823 662063

E: raldridge@illumina.com

W: https://emea.illumina.com

Key contact: Rachel Aldridge/Lily Kremer

NIKON UK LTD

T: 020 8247 1717

E: discover.uk@nikon.com

W: www.nikon.co.uk/en_GB

Key contact: Natalia Alexander H MV

OLYMPUS

T: 01702 616333

E: industrial@olympus.co.uk

W: www.Olympus-lifescience.com

Key contact: Paul Roberts

SCIENTIFIC LABORATORY SUPPLIES

T: 01159 821111

E: slsinfo@scientiﬁc-labs.com

W: www.scientiﬁclabs.co.uk

Key contact: Sandie Flanagan H MV

VECTOR LABORATORIES LTD

T: 01733 237999

E: vector@vectorlabs.co.uk

W: www.vectorlabs.com

Key contact: Dr Ann M Brighty C H

WOODLEY EQUIPMENT COMPANY LTD

T: 012046 69033

E: paulc@woodleyequipment.com

W: www.woodleyequipment.com

Key contact: Customer Services CC HT

ZEISS

T: 01223 401500

E: customercare.uk@zeiss.com

W: www.zeiss.co.uk

Key contact: ZEISS Customer Care H

SAFETY & QUALITY CONTROL

CC Clinical chemistry

C Cytopathology

HT Haemotology & transfusion science

H Histopathology

I Immunology

MV Microbiology & virology

MG Molecular pathology & genomics

AB SCIENTIFIC LTD

T: 020 8396 6171

E: info@abscientiﬁc.com

W: www.abscientiﬁc.com

Key contact: Nigel Baron HT MV

BIOCONNECTIONS

T: 01782 516010

E: welcome@bioconnections.co.uk

W: www.bioconnections.co.uk

Key contact: Andrew Wood MV MG

Our portfolio includes a wide range of diagnostic reagents and reliable instruments including: Carbapenemase Identiﬁcation and Detection Kits

Chromogenic Culture Media

Faecal Parasite Concentrator Kits

IVD Quality Control Reagents

LAMP and Lateral Flow Assays

Susceptibility Testing by BMD

Typing Sera for Salmonella, Shigella, and E. coli.

DIACEUTICS

T: 02678 008163

E: info@diaceutics.com

W: www.diaceutics.com

DON WHITLEY SCIENTIFIC LTD

T: 01274 595728

E: sales@dwscientiﬁc.co.uk

W: www.dwscientiﬁc.com

Key contact: Steve Robertson

MONMOUTH SCIENTIFIC LIMITED

T: 01278 458090

E: info@monmouthscientiﬁc.co.uk

W: www.monmouthscientiﬁc.co.uk

Key contact: Lewis Irish

NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL (NIBSC)

E: business@nibsc.org

W: www.nibsc.org

Key contact: Faraz Farooqi

PATHWAY DIAGNOSTICS

T: 01306 888777

E: info@pathwaydiagnostics.com

W: www.pathwaydiagnostics.com

RANDOX LABORATORIES LTD

T: 02894 422413

E: marketing@randox.com

W: www.randox.com

R-BIOPHARM

T: +49 (0)6151 81020

E: info@r-biopharm.de

W: www.r-biopharm.com

TCS BIOSCIENCE LTD

T: 01296 714222

E: sales@tcsgroup.co.uk

W: www.tcsbiosciences.co.uk

Key contact: Lesley Ayres

TECHNOPATH DISTRIBUTION LTD

T: +353 61 335844

E: info@techno-path.com

W: www.techno-path.com

Key contact: Des Joyce CC I

VEOLIA WATER TECHNOLOGIES

T: 01628 879704

W: www.veoliawatertechnologies.co.uk

6 DISPOSABLES & GENERAL LABORATORY EQUIPMENT

KEY

CC Clinical chemistry

C Cytopathology

HT Haemotology & transfusion science

H Histopathology

I Immunology

MV Microbiology & virology

MG Molecular pathology & genomics

AB SCIENTIFIC LIMITED

T: 020 8396 6171

E: info@abscientiﬁc.com

W: www.abscientiﬁc.com

Key contact: Nigel Baron

ALPHA LABORATORIES LTD

T: 023 8048 3000

E: marketing@alphalabs.co.uk

W: www.alphalabs.co.uk

Key contact: Carole Staniford

ATOM SCIENTIFIC LTD

T: 0161 366 5123

E: enquiries@atomscientiﬁc.com

W: www.atomscientiﬁc.com

Key contact: Yvonne Black

CELLPATH LTD

T: 01686 611333

E: info@cellpath.com

W: www.cellpath.com

Key contact: Stacey Rogers

DON WHITLEY SCIENTIFIC LIMITED

T: 01274 595728

E: sales@dwscientiﬁc.co.uk

W: www.dwscientiﬁc.co.uk

Key contact: Steve Robertson

DX GROUP

T: 0333 241 5100

E: health@thedx.co.uk

W: www.dxdelivery.com

Key contact: Jonathan Ramsey

ELKAY LABORATORY PRODUCTS (UK) LTD

T: 01256 811118

E: sales@elkaylabs.com

W: www.elkaylabs.com

Key contact: Robin Conway

ENFER MEDICAL LTD

T: +353 45 819000

E: generalqueries@enfermedical.ie

W: www.enfermedical.ie

Key contact: Paul Simmons

Enfer Medical Ltd. is an INAB accredited Laboratory, operating to the ISO:15189 Accreditation Standard. It was established to meet the growing demand for large scale on-island medical laboratory testing services and offers diagnostic services in microbiology, haematology, immunology and clinical chemistry disciplines. The service sectors we support include primary care, occupational health, sexual health and research groups. Our laboratories are fully modernised and automated to provide ﬁrst class facilities to both our clients and the staff who work in our laboratories.

GENTA ENVIRONMENTAL LTD

T: 01423 358128

E: info@gentamedical.co.uk

W: www.gentamedical.co.uk

Key contact: Carol Johnson, Claire Redpath

GILSON

T: 0845 519 6872

E: customersupport-uk@gilson.com

W: www.gilson.com

Key contact: Dave Rooks

MWE (MEDICAL WIRE & EQUIPMENT CO. ) LTD.

T: 01225 810361

E: info@mwe.co.uk

W: www.mwe.co.uk

Key contact: Lucy Pulman

MV MG

METTLER TOLDEO LIMITED

T: 0116 235 7070

E: enquire.mtuk@mt.com

W: www.mt.com

MONMOUTH SCIENTIFIC LIMITED

T: 01278 458090

E: info@monmouthscientiﬁc.co.uk

W: www.monmouthscientiﬁc.co.uk

Key contact: Lewis Irish

OLYMPUS

T: 01702 616333

E: industrial@olympus.co.uk

W: www.Olympus-lifescience.com

Key contact: Paul Roberts

PFMMEDICAL UK

T: 01625875388

E: uk@pfmmedical.com

W: www.pfmmedical.co.uk/products/ histotechnology/

Key contact: Jemma Heath

SAKURA FINETEK UK LTD

T: +44 (0)845 070 1638

E: uk@sakura.eu W: www.sakura.e

Key contact: Wesley Gater H

SARSTEDT LIMITED

T: +49 2293 305 0

E: info@sarstedt.com W: www.sarstedt.com/en/home

SCIENTIFIC LABORATORY SUPPLIES

T: 01159 821111

E: slsinfo@scientiﬁc-labs.com W: www.scientiﬁclabs.co.uk Key contact: Sandie Flanagan H MV

SCILABWARE LTD

T: 01782 444406

E: enquiries@scilabware.com W: www.scilabware.com

SHIMADZU

T: 01908552209

E: info@shimadzu.co.uk

W: www.shimadzu.co.uk

Key contact: Patty Pan CC

Shimadzu is one of the largest global providers of analytical instrumentation, responding to customers’ requirements by offering world-class technologies since 1875.

Shimadzu’s complete portfolio covers gas and liquid chromatography as well as mass spectrometry and spectroscopy including IVDR LCMS instrumentation. In addition, Shimadzu provides reagent kits. Shimadzu innovation continues to provide state-of-theart technologies and new solutions to simplify your workflows such as the CLAM-2040, a fully automated sample preparation module for seamless integration with LCMS.

SOLMEDIA LTD

T: +44 (0) 844 8080 900

E: labsupplies@solmedialtd.com

W: www.solmedialtd.com H MV

At Solmedia, we have proudly supplied laboratories across the Country for over 90 years, working closely with our clients to deliver the best products, service and customer support possible. Our passion for support and our drive to improve laboratory performance and results allow us to help labs meet the ever-increasing demands of the industry, supplying reliable products and equipment designed to deliver consistency and compliance, as well as additional services that ensure your equipment continues to perform to the highest standards.